Prosecution Insights
Last updated: October 04, 2026

Wc&F Ip

Technology area: Biotechnology & Pharmaceuticals

168 pending office actions • 106 clients • 158 examiners • 71 art units • 0 of 168 (0%) have an AI response strategy ready • 227 patents granted in the last 365 days

Analysis

WC&F IP handles patent prosecution in the Biotechnology & Pharmaceuticals technology area, with 7276 career applications on record. The firm has a resolved allowance rate of 78.25 percent. Its prosecution history shows an average of 3.25 office actions per allowance. Currently, the firm is managing 134 pending office actions.

The 7276 career applications and 78.25 percent allowance rate establish the firm's historical performance in this sector. The 3.25 average helps practitioners understand the typical procedural requirements for reaching an allowance. With 134 pending office actions, the firm maintains its presence in Biotechnology & Pharmaceuticals. This data set reflects the firm's documented experience and current workload within the patent office. The recorded metrics provide a baseline for procedural duration in this specific field. Practitioners can evaluate the intensity of examiner interaction and resource requirements based on these historical figures. These statistics offer a view of the firm's prosecution profile.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=7276 apps, methodology: how we score firms)

78.2%
Allowance Rate
n=7276
+0.53σ
Allowance Rate (norm)
n=7276
3.2
OAs to Allowance
n=4239
-0.25σ
OAs to Allow (norm)
n=4239
981 days
Time to Allowance
n=4239
+16.7pp
Interview Lift
n=7276
23.5%
RCE Rate
n=7276
2.0%
Appeal Rate
n=7276

Rejection Performance (% of received rejections ultimately overcome)

71.2%
§101 Overcome
n=619
72.2%
§102 Overcome
n=1761
72.8%
§103 Overcome
n=2818
75.3%
§112 Overcome
n=2483

Specialization & Scale

A61K, A61P, G01N
Top CPC Subclasses
26%
Top-3 CPC Share
n=7276
0
Practitioners
n=7276
—
Apps / Practitioner
n=7276 (min 20)

Portfolio Summary

168
Total Pending OAs
101
Non-Final OAs
63
Final Rejections
4
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 56 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

26
Overdue
0
Due this week
17
Due this month
7
Due in next 60 days
6
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 56 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (26)Due ≤ 30 days (17)Due ≤ 60 days (7)Due later (6)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

90
Hard (54%)
55
Medium (33%)
23
Easy (14%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other20 (12%)
§103 only38 (23%)
§102 only3 (2%)
§112 only20 (12%)
Double-patenting only3 (2%)
Double-patenting + other14 (8%)
Multi-statute (no §101)70 (42%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

92
Life Sciences
55% of docket
3
Information Tech
2% of docket
2
Communications
1% of docket
1
Semiconductors
1% of docket
24
Mechanical / Eng
14% of docket
46
Business / Other
27% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,680 h
Manual time on pending OAs
336 h
Time saved (low, 20%)
588 h
Time saved (mid, 35%)
14.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DABKOWSKI, ERINNE R 3 55.9% +69.0%
WILLSE, DAVID H 2 67.3% +13.7%
ALAM, DANYAL HASSAN 2 66.7% +0.0%
BEANE, RANDALL L 2 32.8% +36.8%
YU, DELPHINUS DOU YI 2 33.3% +0.0%
ARMATO JR, DENNIS IGNATIUS 2 42.9% +80.0%
AEDER, SEAN E 2 57.0% +19.9%
SPENCER, MAXIMILIAN TOBIAS 2 32.8% +31.6%
SIMMONS, CHRIS E 2 34.1% +19.4%
NG, JONATHAN K 1 35.6% +14.0%

Hard Cases (90)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18702042 DATA PROCESSING METHOD, DATA PROCESSING DEVICE, AND COMPUTER PROGRAM HAIDER, FAWAAD 131d overdue
17760024 METHODS OF TREATMENT OF CANCER DISEASE BY TARGETING AN EPIGENETIC FACTOR SABILA, MERCY HELLEN 126d overdue
18031251 TG2 INHIBITORS FOR IMPROVING MUCOCILIARY CLEARANCE IN RESPIRATORY DISEASES HIBBERT, CATHERINE S 105d overdue
18247945 GDF3 AS BIOMARKER AND BIOTARGET IN POST-ISCHEMIC CARDIAC REMODELING LUSI, ELLIS FOLLETT 103d overdue
18280151 A STRUCTURAL REPAIR PATCH SYSTEM FOR REPAIRING A DAMAGED SURFACE OF A PRODUCT KOCH, GEORGE R 97d overdue
18006414 GRANULATED EXPLOSIVE BASED ON A WATER-IN-OIL EMULSION, AND PRODUCTION AND USE THEREOF FELTON, AILEEN BAKER 73d overdue
17606618 INTRACORPOREAL GUIDE COMPONENT BACHMAN, LINDSEY MICHELE 51d overdue
18006200 METHODS OF IDENTIFYING AUTISM SPECTRUM DISORDER YU, TIAN NMN 38d overdue

Interview Candidates (16)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18275331 BILE SALTS BACTOSENSOR AND USE THEREOF FOR DIAGNOSITC AND THERAPEUTIC PURPOSES ARMATO JR, DENNIS IGNATIUS 30d overdue
17999638 PROSTHETIC-FOOT INSERT AND FORCE-TRANSMISSION ELEMENT, AND SYSTEM COMPOSED THEREOF SPENCER, MAXIMILIAN TOBIAS 10d overdue
17573913 POLYPEPTIDE FOR USE IN THE PROTECTION OF OXYGEN SENSITIVE GRAM-POSITIVE BACTERIA DABKOWSKI, ERINNE R 10d overdue
17614437 A NEUROPILIN ANTAGONIST IN COMBINATION WITH A P38ALPHA-KINASE INHIBITOR FOR THE TREATMENT OF CANCER SIMMONS, CHRIS E 2d overdue
18553082 PROSTHESIS SOCKET SYSTEM AND METHOD FOR PRODUCING SAME WILLSE, DAVID H 14d
18495355 POLYPEPTIDE FOR USE IN THE PROTECTION OF OXYGEN SENSITIVE GRAM-POSITIVE BACTERIA DABKOWSKI, ERINNE R 43d
17603997 METHODS AND COMPOSITIONS FOR TREATMENT OF NLRP3 INFLAMMASOME MEDIATED IL-1BETA DEPENDENT DISORDERS SIMMONS, CHRIS E 56d
18355853 METHOD FOR SCREENING A SUBJECT FOR CANCER AEDER, SEAN E 62d

Client Portfolio (106 clients)

Client (Assignee)Pending OAs
Ottobock 17
Université Paris Cité 8
VIRGINIA COMMONWEALTH UNIVERSITY 8
AP-HP 5
Université de Montpellier 4
Centre National de la Recherche Scientifique 4
Université de Lyon 4
Audio-Technica 3
Sorbonne Université 3
WASHINGTON STATE UNIVERSITY 3
Université Côte d'Azur 3
Université d'Évry 3
Université Toulouse Iii - Paul Sabatier 2
Université Paris-Saclay 2
Solar Materials GmbH 2
CINOGY GMBH 2
Université De Rouen Normandie 2
CNRS 2
THE HEALTHY AGING COMPANY 2
EBNET MEDICAL GMBH 2
Aix-Marseille Université 2
Yamaguchi University 1
Neurocia SAS 1
Seenel Imaging 1
Hangzhou Dianzi University 1
Université Paris Sciences Et Lettres 1
Promecon Process Measurement Control GmbH 1
Nongxin Technology (Beijing) Co., Ltd. 1
Information Technology Research Center, Beijing Academy Of Agriculture And Forestry Sciences 1
ECOLE SUPÉRIEURE DE PHYSIQUE ET DE CHIMIE INDUSTRIELLES DE LA VILLE DE PARIS 1
Heatex Sensing Technology (Huzhou) Co., Ltd. 1
Faircraft 1
CHINA UNIVERSITY OF GEOSCIENCES (WUHAN) 1
Fondation Asile Des Aveugles 1
NIKKISO CO., LTD. 1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER 1
UNIVERSITE DE POITIERS 1
Children'S Hospital Of Philadelphia (Chop) 1
Greenpharma SAS 1
Institut de Myologie 1
Medykal AG 1
Karl Heesemann Maschinenfabrik GmbH & Co. Kg 1
Association Francaise Contre Les Myopathies (A.F.M.) 1
Centre Hospitalier Universitaire De Reims 1
Institut Pasteur 1
Lexat 1
REMEDEE LABS 1
Xels 1
Centre Hospitalier Regional De Nancy 1
Hörsys GmbH 1
Université De Tours 1
INSTITUT CURIE 1
Laser Zentrum Hannover E.V. 1
SENTEK INSTRUMENT, LLC 1
Mondi 1
Centre Hospitalier Universitaire De Caen Normandie 1
JOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN 1
PK MED 1
CENTRE HOSPITALIER UNIVERSITAIRE D'ANGERS 1
Chongqing University 1
Centre Hospitalier Regional Universitaire De Lille 1
Apteeus 1
TECHNISCHE UNIVERSITÄT BRAUNSCHWEIG 1
CENTRE HOSPTIALIER UNIVERSITAIRE DE TOULOUSE 1
Givaudan S.A. 1
Shangrao Huanli Recycling Technology Co., Ltd. 1
Université Paris-Est Créteil Val De Marne 1
FIN CONTROL SYSTEMS PTY LTD 1
Johns Hopkins University 1
Université de Toulouse 1
INSTITUT RÉGIONAL DU CANCER DE MONTPELLIER 1
Royal Institution For The Advancement Of Learning/Mc Gill University 1
Chuv Centre Hospitalier Universitaire Vaudois 1
Universite Antilles Guyane 1
UNIVERSITE DE VERSAILLES ST QUENTIN EN YVELINES 1
Université d'Orléans 1
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES 1
Chu De Limoges 1
Advanced Energy Materials 1
ECOLE NORMALE SUPERIEURE DE LYON 1
THE SOUTH AFRICAN NUCLEAR ENERGY CORPORATION LIMITED 1
Fundación para la Investigación Médica Aplicada 1
MSW-Chemie 1
Université de Bordeaux 1
Fondamental 1
INSTITUT JEAN PAOLI & IRENE CALMETTES 1
INSERM (Institut Nartional de la Santé et de la Recherche Médicale) 1
Centre Hospitalier Universitaire De Rouen 1
Centrre Hospitalier National D'Ophtalmologie Quinze-Vingts 1
Hemarina 1
Piana Nonwovens LLC 1
Université de Rennes 1
Forschungszentrum Borstel 1
ECOLE SUPERIEURE DE PHYSIQUE ET DE CHIMIE INDUSTRIELLES DE LA VILLE DE PARIS 1
CENTRE LEON BERARD 1
Tiernahrung Deuerer GmbH 1
RAMOT AT TEL-AVIV UNIVERSITY LTD. 1
Helmholtz Association 1
Université de Rouen 1
Conservatoire National des Arts et Métiers (CNAM) 1
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE (CHRU) 1
CORLIFE OHG 1
TRUSTEES OF BOSTON UNIVERSITY 1
Fraunhofer 1
Enios Applications Private Limited Company 1
Fondation Imagine 1

Top Art Units

Art UnitApps
16549
37748
16425
16364
16324
16314
16754
16233
16223
16823

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19134024 ASTHMATIC DISEASE CONDITION ESTIMATION SERVER, ASTHMATIC DISEASE CONDITION ESTIMATION PROGRAM, AND ASTHMATIC DISEASE CONDITION ESTIMATION METHOD Yamaguchi University NG, JONATHAN K 3619 §101§103§112 Non-Final OA — Pending May 29, 2025
19093976 MICROPHONE APPARATUS Audio-Technica Corporation SNIEZEK, ANDREW L §103 Non-Final OA — Pending Mar 28, 2025
19110270 METHODS OF DIAGNOSING ACUTE CIRCULATORY FAILURE Université Toulouse Iii - Paul Sabatier KAUR, GURPREET 1795 §102§103§112 Non-Final OA — Pending Mar 10, 2025
19055896 BODY TISSUE RADIOFREQUENCY APPLICATORS, HEAD DEVICE AND USES THEREOF Neurocia SAS LEE, BRYAN MCALLISTER §103 Non-Final OA — Pending Feb 18, 2025
18997123 INTRAPARTUM MEASUREMENT PROBE AND DEVICE AND DELIVERY MONITORING SYSTEM Seenel Imaging FARDANESH, MARJAN 3792 §102§112 Non-Final OA — Pending Jan 20, 2025
19020113 ELECTROACOUSTIC TRANSDUCER AND HEADPHONE Audio-Technica Corporation SAUNDERS JR, JOSEPH §102§103 Non-Final OA — Pending Jan 14, 2025
19013824 METHOD AND SYSTEM FOR ATTRIBUTE COMMUNITY SEARCH BASED ON RELATION TREE Hangzhou Dianzi University NGUYEN, PHONG H 2156 §101§112 Non-Final OA — Pending Jan 08, 2025
18881505 EXTRACELLULAR VESICLES FUNCTIONALIZED WITH AN ERV SYNCITIN AND USES THEREOF FOR CARGO DELIVERY Université Paris Sciences Et Lettres RONEY, CELESTE A 1615 §103DP Non-Final OA — Pending Jan 06, 2025
19001923 METHOD AND DEVICE FOR MEASURING A FLOW VELOCITY OF A GAS STREAM Promecon Process Measurement Control GmbH WEST, PAUL M §112DP Non-Final OA — Pending Dec 26, 2024
19000830 THREE-DIMENSIONAL (3D) SEMANTIC RECONSTRUCTION METHOD AND APPARATUS OF LEAF, ELECTRONIC DEVICE, AND STORAGE MEDIUM Nongxin Technology (Beijing) Co., Ltd. HARRISON, CHANTE E §102§112 Non-Final OA — Pending Dec 24, 2024
19000803 METHOD AND APPARATUS FOR CALCULATING PLANT HEIGHT UNIFORMITY OF CROP POPULATION, DEVICE, AND MEDIUM Information Technology Research Center, Beijing Academy Of Agriculture And Forestry Sciences WOLFSON, ETHAN NOAH §103 Non-Final OA — Pending Dec 24, 2024
18865879 SELF-POSITIONING ACOUSTIC LENS Ecole Supérieure De Physique Et De Chimie Industrielles De La Ville De Paris HOFFA, ANGELA MARIE 3799 §103§112 Final Rejection 29d overdue Pending Nov 14, 2024
18863355 METHOD FOR PROCESSING 3D IMAGING DATA AND ASSISTING WITH PROGNOSIS OF CANCER Universite Paris-Saclay VARNDELL, ROSS E 2668 §103§112 Non-Final OA — Pending Nov 06, 2024
18862795 METHOD FOR PROCESSING A LAYER ELEMENT Solar Materials GmbH DODDS, SCOTT 1746 §103 Final Rejection — Pending Nov 04, 2024
18860109 PROSTHESIS COVER AND METHOD FOR PRODUCING A PROSTHESIS COVER Otto Bock Healthcare Products GmbH WILLSE, DAVID H 3774 §102§103 Non-Final OA — Pending Oct 25, 2024
18925210 PHOTODETECTOR BASED ON TRANSVERSE DEMBER EFFECT AND PREPARATION METHOD THEREOF Heatex Sensing Technology (Huzhou) Co., Ltd. SECK, AHMED F §103§112 Non-Final OA — Pending Oct 24, 2024
18857952 METHOD FOR PRODUCING LEATHER USING CELL CULTURE ON HONEYCOMB MACROPOROUS POLYMERIC SCAFFOLD Faircraft VIJAYARAGHAVAN, JAGAMYA NMN §103§112DP Non-Final OA — Pending Oct 18, 2024
18826328 VERTICAL DOUBLE-PULSE LASER ABLATION CELL AND USE METHOD THEREOF China University Of Geosciences (Wuhan) VANORE, DAVID A §112 Non-Final OA — Pending Sep 06, 2024
18843732 METHOD FOR DETERMINING A PARAMETER OF THE RESPONSE OF AN AUDITORY NERVE OF A SUBJECT AND ASSOCIATED METHODS AND DEVICES UNIVERSITE DE MONTPELLIER LIU, CHU CHUAN §101§102§112 Non-Final OA — Pending Sep 04, 2024
18837772 PROSTHETIC GLOVE AND METHOD FOR PRODUCING SAME Otto Bock Healthcare Products GmbH WEIS, RAQUEL M. §102§103 Non-Final OA — Pending Aug 12, 2024
18799279 ELECTROACOUSTIC TRANSDUCER Audio-Technica Corporation RINEHART, SEAN MICHAEL 2694 §103 Final Rejection 23d overdue Pending Aug 09, 2024
18786774 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHOROIDAL NEOVASCULARISATION Fondation Asile Des Aveugles RODRIGUEZ, RAYNA B §102§103 Non-Final OA — Pending Jul 29, 2024
18782375 MOTOR BEARING WEAR MONITORING DEVICE, METHOD FOR ADJUSTING MOTOR BEARING WEAR MONITORING DEVICE AND PROGRAM Nikkiso Co., Ltd. SPLIT, JAMES GERALD §112 Non-Final OA — Pending Jul 24, 2024
18782422 DEVICE FOR JOINT EXTRACTION OF A METAL CATION AND A TARGET MOLECULE Centre National De La Recherche Scientifique - Cnrs - MENON, KRISHNAN S §102§103§112 Non-Final OA — Pending Jul 24, 2024
18832633 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING TEAR FILM COMPOSITION TO TREAT CORNEAL DEFECTS Centre Hospitalier Universitaire De Montpellier JACKSON III, WALTER §102§103 Non-Final OA — Pending Jul 24, 2024
18730927 COMPOUND FOR USE IN PREVENTING AND/OR TREATING AN INFECTION CAUSED BY SARS-COV-2 UNIVERSITE PARIS CITE JAUHARI, SACHI §103Other Non-Final OA — Pending Jul 22, 2024
18772744 CONSTRUCTS COMPRISING NEURONAL VIABILITY FACTORS AND USES THEREOF Sorbonne Universite AMICK, THOMAS RUSSE DP Non-Final OA — Pending Jul 15, 2024
18727787 A COMPOSITION COMPRISING LIPID NANOPARTICLES AND AN ANTIFUNGAL POLYENE UNIVERSITE DE POITIERS GULLEDGE, BRIAN M 1699 §103§112 Final Rejection — Pending Jul 10, 2024
18727826 NALTREXAMINE DERIVATIVES BEARING 5-MEMBER HETEROCYCLIC RING SYSTEMS AND OPIOID RECEPTOR MODULATORS VIRGINIA COMMONWEALTH UNIVERSITY STOCKTON, LAURA LYNNE §102§112Other Non-Final OA — Pending Jul 10, 2024
18767363 BENZALDEHYDE COMPOUNDS WITH DIRECT POLYMER DESTABILIZING EFFECTS TO TREAT SICKLE CELL DISEASE Children'S Hospital Of Philadelphia (Chop) ANDERSON, REBECCA L DP Non-Final OA — Pending Jul 09, 2024
18725323 GERALEXIN AND USES THEREOF FOR THE TREATMENT OF RETINAL DEGENERATIVE DISEASES Greenpharma SAS VISHNYAKOVA, ELENA VLADIMIROVNA §101§112 Non-Final OA — Pending Jun 28, 2024
18725322 METHODS OF INDUCING CELL DEATH OF A POPULATION OF SOLID TUMOR CELLS UNIVERSITE PARIS CITE CONSTANTINE, CHARLES Z 1657 §112 Non-Final OA — Pending Jun 28, 2024
18748524 ADJUSTMENT VALVE Otto Bock Healthcare Products GmbH MANNAN, MIKAIL A §102§103Other Non-Final OA — Pending Jun 20, 2024
18721781 BENZENE SULFONAMIDE THIAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCERS Centre National De La Recherche Scientifique CHICKS, ASHLI ARIANA §102§103§112DP Final Rejection — Pending Jun 19, 2024
18720245 Method for Controlling a Prosthetic and/or Orthotic System and such a System Otto Bock Healthcare Products GmbH STRANSKY, KATRINA MARIE §102§103§112 Non-Final OA — Pending Jun 14, 2024
18718997 ORTHOPAEDIC DEVICE AND METHOD FOR PRODUCING SAME Otto Bock Healthcare Products GmbH PATEL, NITIN §102 Non-Final OA — Pending Jun 12, 2024
18718508 ACTUATOR AND ORTHOPEDIC TECHNICAL JOINT DEVICE, AND METHOD FOR CONTROLLING SAME Otto Bock Healthcare Products GmbH COCHRAN, KARI LEE §102§103 Non-Final OA — Pending Jun 11, 2024
18718498 PROSTHETIC SOCKET Ottobock SE & Co. Kgaa GHERBI, SUZETTE JAIME J 3774 §102§103 Non-Final OA — Pending Jun 11, 2024
18717719 USE OF CATECHIN FOR THE TREATMENT OF FGFR-RELATED BONE REPAIR AND BONE FORMATION IMPAIRMENT Assistance Publique-Hôpitaux De Paris (Aphp) MCMILLIAN, KARA RENITA §103§112Other Non-Final OA — Pending Jun 07, 2024
18735636 Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism Association Institut De Myologie WESTON, ALYSSA G §102§103§112DPOther Non-Final OA — Pending Jun 06, 2024
18676570 METHODS OF PREPARING PLANT-BASED PREPREGS FOR COMPOSITE LAMINATES Washington State University MALEKZADEH, SEYED MASOUD 1754 §103 Non-Final OA 84d Pending May 29, 2024
18712487 METHOD FOR PREDICTING THE RISK OF THE OCCURRENCE OF SUDDEN DEATH AND ASSOCIATED DEVICES Medykal AG LI, SUN M 3685 §101§102§103 Non-Final OA — Pending May 22, 2024
18668640 GRINDING MACHINE FOR GRINDING A SURFACE OF AN OBJECT Karl Heesemann Maschinenfabrik GmbH & Co. Kg MARKMAN, MAKENA 4100 §102§103§112 Non-Final OA — Pending May 20, 2024
18710918 METHOD FOR GENERATING ACOUSTIC FEEDBACK, AND ORTHOPAEDIC DEVICE Otto Bock Healthcare Products GmbH MASIH, KAREN §103§112 Non-Final OA — Pending May 16, 2024
18708662 DERIVATIVES OF NIFUROXAZIDE FOR USE IN THE TREATMENT OF MITOCHONDRIAL DISORDERS AND NEURODEGENERATIVE DISEASES Association Francaise Contre Les Myopathies (A.F.M.) SHAMEEM, GOLAM M §112 Non-Final OA — Pending May 09, 2024
18706569 METHOD AND DEVICE FOR PROCESSING A SOLAR MODULE Solar Materials GmbH MEKHLIN, ELI S 1759 §102§103§112 Non-Final OA — Pending May 01, 2024
18706622 USE OF LOW MOLECULAR WEIGHT HYALURONIC ACID FOR THE TREATMENT OF LUNG MUCOSAL INFLAMMATION Centre Hospitalier Universitaire De Reims GALSTER, SAMUEL LEONARD 1693 §102§103DP Non-Final OA — Pending May 01, 2024
18706610 LENTIVIRAL VECTOR FOR EXPRESSION OF HUMAN PAPILLOMAVIRUS (HPV) ANTIGENS AND ITS IMPLEMENTATION IN THE TREATMENT OF HPV INDUCED CANCERS Institut Pasteur ALAM, DANYAL HASSAN §103§112DP Non-Final OA — Pending May 01, 2024
18704239 ELBOW ORTHOSIS AND PROCESS FOR ADAPTING A CONFIGURATION OF SUCH AN ORTHOSIS TO A PATIENT Lexat MILLER, DANIEL A 3786 §103§112 Non-Final OA 34d Pending Apr 24, 2024
18644602 MODULE AND DEVICE FOR TREATING OSTEOARTHRITIS USING EMITTING ELECTROMAGNETIC WAVES Remedee Labs LANDEEN, BROGAN RANE §112DP Non-Final OA — Pending Apr 24, 2024
18704329 PLASMA TREATMENT DEVICE FOR PLASMA TREATMENT OF A SKIN SURFACE Cinogy GmbH BORSCH, NICHOLAS S §103 Non-Final OA — Pending Apr 24, 2024
18704302 PLASMA TREATMENT DEVICE FOR PLASMA TREATMENT OF A SKIN SURFACE Cinogy GmbH TEMPLETON, MARINA DELANEY 3794 §103 Final Rejection — Pending Apr 24, 2024
18638895 HIGH TEMPERATURE END EFFECTORS FOR ROBOTS VIRGINIA COMMONWEALTH UNIVERSITY KIM, SANG K §103§112 Non-Final OA — Pending Apr 18, 2024
18702042 DATA PROCESSING METHOD, DATA PROCESSING DEVICE, AND COMPUTER PROGRAM Xels Japan Co., Ltd. HAIDER, FAWAAD 3627 §101§103 Non-Final OA 131d overdue Pending Apr 17, 2024
18701785 DNA METHYLATION SIGNATURE FOR DIAGNOSING HEPATOCELLULAR CARCINOMA Centre Hospitalier Regional De Nancy CASH, KAILEY ELIZABETH §101§102§112 Non-Final OA — Pending Apr 16, 2024
18698509 USE OF LAURYL GALLATE (LG) AS A HEMOSTATIC AGENT Université Toulouse Iii - Paul Sabatier CHONG, YONG SOO 1623 §102§103 Final Rejection — Pending Apr 04, 2024
18691590 ORTHOPEDIC SYSTEM AND PROSTHETIC FOOT HAVING SUCH AN ORTHOPEDIC SYSTEM Ottobock SE & Co. Kgaa LOPEZ, LESLIE ANN §102§103§112 Non-Final OA — Pending Mar 13, 2024
18689551 PATIENT-SPECIFIC IMPLANT AND METHOD FOR ITS MANUFACTURE Hörsys GmbH BOSWORTH, KAMI A §103 Final Rejection — Pending Mar 06, 2024
18593023 BRAIN PHANTOM WITH EMBEDDED SENSORS FOR BRAIN INJURY MODELING VIRGINIA COMMONWEALTH UNIVERSITY FRENCH, CORRELL T 3715 §103§112 Final Rejection — Pending Mar 01, 2024
18687526 ORTHOPAEDIC DEVICE Ottobock SE & Co. Kgaa BLANCO, JAVIER G 3774 §102§103 Non-Final OA — Pending Feb 28, 2024
18687496 USE OF BRANCHED CHAIN FATTY ACIDS (BCFAS) FOR THE TREATMENT OF INTESTINAL INFLAMMATION Université De Rouen Normandie VAJDA, KRISTIN ANN 1622 §102§112 Non-Final OA — Pending Feb 28, 2024
18685000 METHODS FOR TREATING AUTISM SPECTRUM DISORDERS Université De Tours MAYHEW, BRADLEY SCOTT 1621 §103 Non-Final OA — Pending Feb 20, 2024
18684020 USE OF ETV3 OR ETV6 INHIBITORS FOR BLOCKING THE DIFFERENTIATION OF MONOCYTES INTO DENDRITIC CELLS Institut Curie KONOPKA, CATHERINE ANNE §103 Final Rejection — Pending Feb 15, 2024
18442706 ENDOSCOPE AND METHOD FOR OPERATION Laser Zentrum Hannover E.V. SONG, LI-TING 3795 §103§112 Final Rejection — Pending Feb 15, 2024
18260172 SYSTEMS AND METHODS FOR FIBER OPTIC FOURIER SPECTROMETRY MEASUREMENT Sentek Instrument, LLC CARLSON, JOSHUA MICHAEL 2877 §103§112 Final Rejection 26d Pending Feb 13, 2024
18683083 USE OF EZH2 INHIBITORS FOR THE TREATMENT OF AORTIC VALVE STENOSIS Université De Rouen Normandie FLORES, ADRIAN 3774 §102§103 Non-Final OA — Pending Feb 12, 2024
18293611 METHOD FOR PACKAGING AN OBJECT IN A PAPER BAG, AND PAPER BAG Mondi AG BATTISTI, DEREK J 3734 §102§112 Non-Final OA — Pending Jan 30, 2024
18291693 COMPOSITION FOR CAPTURING LEAD AND/OR CADMIUM IN A DIALYSIS FLUID Centre National De La Recherche Scientifique - Cnrs - KRISHNAN, GANAPATHY §101§103§112DP Non-Final OA — Pending Jan 24, 2024
18291677 SELF-ASSEMBLED BIOCOMPATIBLE IMAGING PARTICLES, THEIR SYNTHESIS AND THEIR USE IN IMAGING TECHNIQUES Centre Hospitalier Universitaire De Caen Normandie BAEK, JONGHWAN NMN §103§112DP Non-Final OA — Pending Jan 24, 2024
18418493 ALLELE-SPECIFIC SILENCING THERAPY FOR DYNAMIN 2-RELATED DISEASES Centre National De La Recherche Scientifique (Cnrs) WHITEMAN, BRIAN A 1636 §112 Non-Final OA — Pending Jan 22, 2024
18579953 GRAM-NEGATIVE BACTERIA EFFLUX PUMP INHIBITORS Johann Wolfgang Goethe-Universität Frankfurt Am Main SHTERENGARTS, SAMANTHA L 1623 §102§112 Non-Final OA — Pending Jan 17, 2024
18577572 COMPOUND OF THE 7A,8,9,10,11,11A-HEXAHYDRO-1H,7H-PYRANO[2,3-C]XANTHENE TYPE, METHOD OF PREPARATION THEREOF, INTERMEDIATES THEREOF AND THERAPEUTIC APPLICATIONS THEREOF UNIVERSITE COTE D'AZUR RZECZYCKI, PHILLIP MATTHEW 1625 §112 Final Rejection — Pending Jan 08, 2024
18576452 DOSAGE FORM FOR INTRA-ARTICULAR INJECTION COMPRISING COLCHICINE FOR USE IN THE TREATMENT OF CRYSTAL-AND NON-CRYSTAL ASSOCIATED ACUTE INFLAMMATORY ARTHRITIS Pk Med YU, HONG 1614 §103 Final Rejection 34d Pending Jan 04, 2024
18575431 GENE SIGNATURES FOR PREDICTING SURVIVAL TIME IN PATIENTS SUFFERING FROM RENAL CELL CARCINOMA UNIVERSITE COTE D'AZUR WILDER, CYNTHIA B §101§112 Non-Final OA — Pending Dec 29, 2023
18575454 NEW METHOD TO TREAT ACIDOSIS RELATED DISEASES WITH ACETOACETATE Centre Hospitalier Universitaire D'Angers GONZALEZ, LUISALBERTO 1624 §102§103§112 Non-Final OA 27d Pending Dec 29, 2023
18571893 USE OF IL-36 INHIBITORS FOR THE TREATMENT OF NETHERTON SYNDROME UNIVERSITE PARIS CITE BUTTICE, AUDREY L §102§103§112 Non-Final OA — Pending Dec 19, 2023
18540180 ELECTROCHEMICAL REGENERATION METHOD OF ACTIVATED CARBON Chongqing University NGUYEN, CAM N 4100 §112 Non-Final OA — Pending Dec 14, 2023
18569392 AEROSOL COMPOSITION FOR PULMONARY DELIVERY OF FLAGELLIN Centre Hospitalier Regional Universitaire De Lille BEANE, RANDALL L 1654 §103§112DP Non-Final OA — Pending Dec 12, 2023
18561797 METHODS AND COMPOSITIONS FOR TREATING PULMONARY ALVEOLAR PROTEINOSIS RELATED TO MARS MUTATIONS Assistance Publique-Hôpitaux De Paris (Aphp) HERNANDEZ, JACKSON J 1627 §103 Final Rejection 43d Pending Nov 17, 2023
18290096 HLA-DELETED GLOMERULAR ENDOTHELIAL CELLS AND DIAGNOSTIC METHOD USING THEREOF Assistance Publique - Hôpitaux de Paris COUNTS, GARY W 1677 §112 Non-Final OA — Pending Nov 09, 2023
18559411 USE OF CLOFOCTOL FOR THE TREATMENT OF INFLAMMATION Apteeus HASTINGS, ALISON AZAR 1627 §103§112DP Non-Final OA 75d Pending Nov 07, 2023
18495355 POLYPEPTIDE FOR USE IN THE PROTECTION OF OXYGEN SENSITIVE GRAM-POSITIVE BACTERIA The Healthy Aging Company DABKOWSKI, ERINNE R 1654 §101§103§112 Final Rejection 43d Pending Oct 26, 2023
18492040 MIT NANOKOMPOSIT MODIFIZIERTER ASPHALTBINDER UND DESSEN HERSTELLUNG Technische Universität Braunschweig WEISS, PAMELA HL 1732 §103 Final Rejection 98d overdue Pending Oct 23, 2023
18491138 G-PROTEIN-GATED-K+ CHANNEL-MEDIATED ENHANCEMENTS IN LIGHT SENSITIVITY IN ROD-CONE DYSTROPHY (RCD) Sorbonne Universite WRIGHT, ERIC BRANDON 1632 §102§103§112DP Non-Final OA — Pending Oct 20, 2023
18247982 METHOD AND COMPUTER PROGRAM FOR CREATING MANUFACTURING DATA, AND METHOD FOR MANUFACTURING AN ORTHOPEDIC DEVICE Ottobock SE & Co. Kgaa KARIM, ZIAUL 2119 §103 Final Rejection 42d overdue Pending Oct 10, 2023
18481306 METHODS FOR SCREENING A SUBJECT FOR A CANCER UNIVERSITE DE MONTPELLIER KENNEDY, SARAH JANE 1682 §101§103Other Non-Final OA 4d overdue Pending Oct 05, 2023
18285585 METHODS FOR THE TREATMENT OF ANAPLASTIC LARGE CELL LYMPHOMA Centre Hosptialier Universitaire De Toulouse NATARAJAN, MEERA 1643 §103§112 Non-Final OA — Pending Oct 04, 2023
18553246 PROSTHETIC FOOT INSERT Ottobock SE & Co. Kgaa NGUYEN, NHA UYEN CHAU 3774 §102§103 Non-Final OA 83d Pending Sep 29, 2023
18553310 CHONDROITIN-PRODUCING RECOMBINANT CELL Givaudan SA EIX, EMILY FAY 1653 §102§103 Non-Final OA — Pending Sep 29, 2023
18553082 PROSTHESIS SOCKET SYSTEM AND METHOD FOR PRODUCING SAME Ottobock SE & Co. Kgaa WILLSE, DAVID H 3774 §102 Final Rejection 14d Pending Sep 28, 2023
18552054 TREM-1 INHIBITORS FOR THE TREATMENT OF MARFAN SYNDROME UNIVERSITE PARIS CITE BRADLEY, CHRISTINA 1654 §103§112 Non-Final OA — Pending Sep 22, 2023
18471774 REDUCTION ROASTING DEVICE AND METHOD FOR RECOVERING LITHIUM FROM WASTE LITHIUM BATTERY Shangrao Huanli Recycling Technology Co., Ltd. POLLOCK, AUSTIN M 1738 §103 Non-Final OA — Pending Sep 21, 2023
18471689 VALVE AND PROSTHETIC KNEE JOINT HAVING SUCH A VALVE Ottobock SE & Co. Kgaa WOZNICKI, JACQUELINE §102§103 Non-Final OA — Pending Sep 21, 2023
18282667 METHODS FOR THE DIAGNOSIS AND TREATMENT OF T CELL-LYMPHOMAS Université Paris-Est Créteil Val De Marne XIAO, YAN 1642 §102§112 Final Rejection — Pending Sep 18, 2023
18280151 A STRUCTURAL REPAIR PATCH SYSTEM FOR REPAIRING A DAMAGED SURFACE OF A PRODUCT Fin Control Systems Pty Ltd. KOCH, GEORGE R 1745 §103§112 Final Rejection 97d overdue Pending Sep 01, 2023
18278494 ALLELE-SPECIFIC GENOME EDITING OF THE NR2E3 MUTATION G56R UNIVERSITE DE MONTPELLIER POLIAKOVA-GEORGAN, EKATERINA 1637 §101§103 Final Rejection — Pending Aug 23, 2023
18276140 MINI CIRCULAR RNA THERAPEUTICS AND VACCINES AND METHODS OF USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY YU, DELPHINUS DOU YI 1636 §103 Non-Final OA — Pending Aug 07, 2023
18364891 Click chemistry hydrogel with minimal swelling as a dural sealant and local delivery vehicle for recombinant proteins and other bioactive agents Johns Hopkins University ATKINSON, JOSHUA ALEXANDER 1612 §103DP Non-Final OA — Pending Aug 03, 2023
18275331 BILE SALTS BACTOSENSOR AND USE THEREOF FOR DIAGNOSITC AND THERAPEUTIC PURPOSES UNIVERSITE DE MONTPELLIER ARMATO JR, DENNIS IGNATIUS 1651 §103 Final Rejection 30d overdue Pending Aug 01, 2023
18263014 METHODS OF ASSESSING THE RISK OF DEVELOPING PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN PATIENTS TREATED WITH VLA-4 ANTAGONISTS UNIVERSITE PAUL SABATIER TOULOUSE III LU, CHENG 1642 §112 Non-Final OA 15d Pending Jul 26, 2023
18355853 METHOD FOR SCREENING A SUBJECT FOR CANCER Institut Régional Du Cancer De Montpellier AEDER, SEAN E 1642 §103§112 Final Rejection 62d Pending Jul 20, 2023
18268692 NOVEL RECOMBINANT FRAGMENTS OF FIBRILLIN-1 AND METHODS OF USE THEREOF Royal Institution For The Advancement Of Learning/Mc Gill University BOWLES, DAVID PAUL 1654 §101§102§103§112 Non-Final OA — Pending Jun 21, 2023
18258587 PULSATIVE GNRH ADMINISTRATION FOR TREATING FOOD INTAKE RELATED DISORDERS Chuv Centre Hospitalier Universitaire Vaudois BEANE, RANDALL L 1654 §103DPOther Final Rejection — Pending Jun 21, 2023
18257438 USE OF DRUGS THAT STIFFEN MATURE GAMETOCYTES FOR BLOCKING TRANSMISSION OF PLASMODIUM PARASITES Universite Antilles Guyane LEE, WILLIAM Y 1623 §102§103 Non-Final OA — Pending Jun 14, 2023
18266034 SUBSTANCES AND METHODS FOR TREATING DYSTROPHIC EPIDERMOLYSIS BULLOSA UNIVERSITE DE VERSAILLES ST QUENTIN EN YVELINES ZARA, JANE J 1637 §112 Final Rejection 21d Pending Jun 08, 2023
18038970 METHODS FOR DIAGNOSIS AND MONITORING OF TOXIC EPIDERMAL NECROLYSIS UNIVERSITE CLAUDE BERNARD - LYON 1 AEDER, SEAN E 1642 §112 Final Rejection — Pending May 25, 2023
18038734 EFFICIENT AND RAPID SPECIFICATION OF SPINAL NEURONAL SUBTYPES FROM HUMAN PLURIPOTENT STEM CELLS UNIVERSITE DE PARIS-SACLAY DHAR, MATASHA 1632 §102§103§112 Final Rejection 25d overdue Pending May 25, 2023
18253953 RADIOLABELLED COMPOUNDS FOR DIAGNOSING CHOLINERGIC NEURODEGENERATIVE DISEASES UNIVERSITE D'ORLEANS VU, JAKE MINH 1618 §102§103 Final Rejection — Pending May 23, 2023
18253529 USE OF MICRORNA INHIBITION TO PREVENT AND TREAT OSTEOARTHRITIS AND OTHER INFLAMMATORY DISEASES VIRGINIA COMMONWEALTH UNIVERSITY YU, DELPHINUS DOU YI 1636 §112 Final Rejection — Pending May 18, 2023
18251809 METHODS FOR THE DIAGNOSIS AND THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE Centre Hospitalier Universitaire De Nantes CUNNINGCHEN, KATHLEEN MARY 1646 §103§112 Final Rejection — Pending May 04, 2023
18250273 METHOD FOR ASSESSING THE AREA UNDER THE CURVE OF AN IMMUNOSUPRESSANT AND ASSOCIATED METHOD AND SYSTEMS Chu De Limoges MINCHELLA, KAITLYN L §101§103§112 Non-Final OA — Pending Apr 24, 2023
18305809 METHODS FOR PERFORMING ANTISENSE OLIGONUCLEOTIDE-MEDIATED EXON SKIPPING IN THE RETINA OF A SUBJECT IN NEED THEREOF Assistance Publique - Hôpitaux de Paris GIBBS, TERRA C 1635 §112 Final Rejection 121d overdue Pending Apr 24, 2023
18304022 MICRODEVICES AND PROCESSES TO SEPARATE AND PROCESS MIXED FORENSIC BIOLOGICAL SAMPLES VIRGINIA COMMONWEALTH UNIVERSITY TICHY, JENNIFER M.H. 1653 §103 Non-Final OA — Pending Apr 20, 2023
18031249 TARGETED-ANTIBACTERIAL-PLASMIDS COMBINING CONJUGATION AND CRISPR/CAS SYSTEMS AND USES THEREOF UNIVERSITE CLAUDE BERNARD - LYON 1 WARD, AARON DUREL 1636 §102§103§112 Non-Final OA 29d Pending Apr 11, 2023
18031251 TG2 INHIBITORS FOR IMPROVING MUCOCILIARY CLEARANCE IN RESPIRATORY DISEASES Assistance Publique-Hôpitaux De Paris (Aphp) HIBBERT, CATHERINE S 1658 §102§112 Non-Final OA 105d overdue Pending Apr 11, 2023
18247945 GDF3 AS BIOMARKER AND BIOTARGET IN POST-ISCHEMIC CARDIAC REMODELING UNIVERSITE PARIS CITE LUSI, ELLIS FOLLETT 1677 §101§102§103§112 Non-Final OA 103d overdue Pending Apr 05, 2023
18030160 A FACTOR H BINDING PROTEIN B (FHBB) BASED CHIMERIC VACCINE FOR THE PREVENTION AND TREATMENT OF PERIODONTAL DISEASE VIRGINIA COMMONWEALTH UNIVERSITY GRASER, JENNIFER E 1645 §102§112 Non-Final OA 19d overdue Pending Apr 04, 2023
18246270 BIFUNCTIONAL LENTIVIRAL VECTORS ALLOWING THE BS-GLOBIN SILENCING AND EXPRESSION OF AN ANTI-SICKLING HBB AND USES THEREOF FOR GENE THERAPY OF SICKLE CELL DISEASE UNIVERSITE DE PARIS QIAN, CELINE X 1637 §103 Final Rejection 29d Pending Mar 22, 2023
18120673 MIXED METAL OXIDE POWDERS AND METHODS FOR MANUFACTURING THEREOF Advanced Energy Materials, LLC RUMP, RICHARD M 1759 §102§112 Non-Final OA 75d Pending Mar 13, 2023
18174182 LENTIVIRAL VECTOR EXPRESSING MEMBRANE-ANCHORED OR SECRETED ANTIBODY Ecole Normale Superieure De Lyon LEONARD, ARTHUR S 1631 §103§112 Final Rejection — Pending Feb 24, 2023
18041313 THERANOSTIC COMPOUNDS The South African Nuclear Energy Corporation Limited WEBB, WALTER E 1612 §103 Final Rejection 75d Pending Feb 10, 2023
18041142 GENE THERAPY VECTOR EXPRESSING CYP27A1 FOR THE TREATMENT OF CEREBROTENDINOUS XANTHOMATOSIS Fundacion Para La Investigacion Medica Aplicada HUMPHRIES, NICHOLAS ADAM 1631 §103 Final Rejection 22d overdue Pending Feb 09, 2023
18006414 GRANULATED EXPLOSIVE BASED ON A WATER-IN-OIL EMULSION, AND PRODUCTION AND USE THEREOF Msw-Chemie GmbH FELTON, AILEEN BAKER 1734 §102§103 Final Rejection 73d overdue Pending Jan 23, 2023
18006200 METHODS OF IDENTIFYING AUTISM SPECTRUM DISORDER Washington State University YU, TIAN NMN 1681 §102§103§112 Non-Final OA 38d overdue Pending Jan 20, 2023
18006030 TRAINING METHOD AND MODEL FOR PREDICTING INHIBITORS OF DRUGS METABOLIZING ENZYMES Sorbonne Universite DARRIGRAND, EMILY ANN §101§102§103§112 Non-Final OA — Pending Jan 19, 2023
18156609 ORTHOPAEDIC DEVICE FOR SUPPORTING A LOWER EXTREMITY OF A USER Ottobock SE & Co. Kgaa HOWELL, GWYNNETH LINNEA 3785 §102§103§112 Final Rejection — Pending Jan 19, 2023
18003949 METHODS FOR THE DETECTION OF LENGTH POLYMORPHISMS VIRGINIA COMMONWEALTH UNIVERSITY JOHANNSEN, DIANA B 1682 §103§112 Final Rejection — Pending Dec 30, 2022
18003999 METHODS FOR PREDICTING THE RISK OF RECURRENCE AND/OR DEATH OF PATIENTS SUFFERING FROM A SOLID CANCER AFTER PREOPERATIVE ADJUVANT THERAPY AND RADICAL SURGERY UNIVERSITE PARIS CITE DENT, ALANA HARRIS 1643 DP Final Rejection 16d Pending Dec 30, 2022
18013339 Method for Engineering Novel Hybrid AAV Capsids Through Hyper Variable Regions Swapping UNIVERSITE D'EVRY VAL D'ESSONNE BOESEN, CHRISTIAN C 1684 §102 Non-Final OA — Pending Dec 28, 2022
18003274 METHODS OF TREATMENT AND DIAGNOSTIC OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH INTENSE STRESS UNIVERSITE DE BORDEAUX MUI, CHRISTINE T 1797 §101§102§103 Non-Final OA 4d overdue Pending Dec 23, 2022
18001420 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FGFR3-RELATED COGNITIVE DEFICIT Centre National De La Recherche Scientifique (Cnrs) NOTTINGHAM, KYLE GREGORY 1621 §112 Non-Final OA 28d Pending Dec 09, 2022
18009006 Treatment of Genetic Dilated Cardiomyopathies UNIVERSITE D'EVRY VAL D'ESSONNE CONNORS, ALEXANDRA F 1634 §103§112 Final Rejection 30d overdue Pending Dec 08, 2022
17927764 ANTI-HERV-W ENVELOPE PROTEIN ANTIBODY FOR USE IN THE TREATMENT OF PSYCHOTIC DISEASES Fondamental CHERNYSHEV, OLGA N 1675 §112 Non-Final OA — Pending Nov 25, 2022
17999669 COSMESIS, SYSTEM CONSISTING OF PROSTHETIC COMPONENT AND COSMESIS, AND CONNECTION PART Otto Bock Healthcare Products GmbH SPENCER, MAXIMILIAN TOBIAS 3774 §103 Non-Final OA — Pending Nov 22, 2022
17999638 PROSTHETIC-FOOT INSERT AND FORCE-TRANSMISSION ELEMENT, AND SYSTEM COMPOSED THEREOF Ottobock SE & Co. Kgaa SPENCER, MAXIMILIAN TOBIAS 3774 §103§112 Final Rejection 10d overdue Pending Nov 22, 2022
17998584 NEW METHOD TO TREAT CUTANEOUS T-CELL LYMPHOMAS AND TFH DERIVED LYMPHOMAS Institut Jean Paoli & Irene Calmettes CHASE, CAROL ANN 1646 §103 Non-Final OA 13d Pending Nov 11, 2022
17996901 ANIMAL MODEL FOR STUDYING CANCER IMMUNOTHERAPY INSERM STAVROU, CONSTANTINA E 1632 §103 Final Rejection — Pending Oct 21, 2022
17996294 METHODS FOR DETECTING THE PRESENCE OF CORONAVIRUS-SPECIFIC ANTIBODIES IN A SUBJECT Centre Hospitalier Universitaire De Rouen ALAM, DANYAL HASSAN 1600 §101§103§112 Final Rejection — Pending Oct 14, 2022
17995880 G-PROTEIN-GATED-K+ CHANNEL-MEDIATED ENHANCEMENTS IN LIGHT SENSITIVITY IN ROD-CONE DYSTROPHY (RCD) Centrre Hospitalier National D'Ophtalmologie Quinze-Vingts PENNINGTON, KATIE LEIGH 1634 §103 Final Rejection — Pending Oct 10, 2022
17995809 USE OF VIDOFLUDIMUS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS UNIVERSITE CLAUDE BERNARD - LYON 1 HAVLIN, ROBERT H 1626 §103 Final Rejection 31d overdue Pending Oct 07, 2022
17995038 USE OF HAEMOGLOBIN FROM ANNELIDS FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME Hemarina FIEBIG, RUSSELL G 1655 §103 Non-Final OA — Pending Sep 29, 2022
17935625 CONSUMER GOODS MADE WITH PIECES OF VERTICALY LAPPED NONWOVEN Piana Nonwovens LLC CONLEY, FREDRICK C 3679 §103 Final Rejection — Pending Sep 27, 2022
17906268 NEW STRATEGY TO TREAT AND PREVENT DISEASES CAUSED BY ENTEROBACTERIAE UNIVERSITE DE RENNES ARMATO JR, DENNIS IGNATIUS 1651 §103§112 Final Rejection — Pending Sep 14, 2022
17905290 PROCESS FOR OBTAINING A PRE-VASCULARIZED DERMAL-EPIDERMAL TISSUE UNIVERSITE D'EVRY VAL D'ESSONNE SCHUBERG, LAURA J 1631 §103 Final Rejection — Pending Aug 30, 2022
17904544 METHOD FOR DIAGNOSIS AND TREATMENT MONITORING AND INDIVIDUAL THERAPY END DECISION IN TUBERCULOSIS INFECTION Forschungszentrum Borstel Leibniz-Lungenzentrum KAPUSHOC, STEPHEN THOMAS 1683 §101§112 Final Rejection — Pending Aug 18, 2022
17818481 NEW TAU SPECIES Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris FONTAINHAS, AURORA M 1675 §103§112 Final Rejection 29d Pending Aug 09, 2022
17760024 METHODS OF TREATMENT OF CANCER DISEASE BY TARGETING AN EPIGENETIC FACTOR Centre Leon Berard SABILA, MERCY HELLEN 1654 §103§112 Non-Final OA 126d overdue Pending Aug 03, 2022
17740689 Method for producing and preserving a semimoist animal feed, and semimoist animal feed in a substantially gas-tight packaging unit Tiernahrung Deuerer GmbH GERLA, STEPHANIE RAE 1791 §103§112 Final Rejection 33d Pending May 10, 2022
17767212 SECURING DEVICE AND ASSEMBLY COMPRISING A RETAINING ELEMENT AND A SECURING DEVICE Ebnet Medical GmbH ALLEN, ROBERT F 3783 §103 Final Rejection 12d Pending Apr 07, 2022
17640823 ASSOCIATION BETWEEN 4 COPIES OF EXON 3 OF fAIM AND PROGRESSIVE CHRONIC KIDNEY DISEASE IN CATS Washington State University MYERS, CARLA J 1682 §101§103§112 Final Rejection 15d Pending Mar 06, 2022
17637682 METHODS AND COMPOSITIONS FOR TREATING PAX6-DEFICIENCY RELATED DISEASE Ramot AT Tel-Aviv University Ltd. PATTERSON, SARAH COOPER 1675 §112 Final Rejection — Pending Feb 23, 2022
17636536 NEW USE OF CYCLIC DINUCLEOTIDES Helmholtz-Zentrum für Infektionsforschung GmbH CHO, DAVID H 1693 §103Other Non-Final OA 100d overdue Pending Feb 18, 2022
17629956 Osteocrin, Lebetin or ANP for Destroying Bacterial Biofilms UNIVERSITE DE ROUEN NORMANDIE MARTINEZ, TARA L 1654 §103§112 Final Rejection 29d Pending Jan 25, 2022
17573913 POLYPEPTIDE FOR USE IN THE PROTECTION OF OXYGEN SENSITIVE GRAM-POSITIVE BACTERIA The Healthy Aging Company DABKOWSKI, ERINNE R 1654 §112 Non-Final OA 10d overdue Pending Jan 12, 2022
17614437 A NEUROPILIN ANTAGONIST IN COMBINATION WITH A P38ALPHA-KINASE INHIBITOR FOR THE TREATMENT OF CANCER Conservatoire National Des Arts Et Métiers (Cnam) SIMMONS, CHRIS E 1622 §103 Final Rejection 2d overdue Pending Nov 26, 2021
17607676 PULSATIVE GNRH ADMINISTRATION FOR TREATING COGNITIVE DISORDERS Centre Hospitalier Regional Et Universitaire De Lille (Chru) DABKOWSKI, ERINNE R 1654 §103 Non-Final OA — Pending Oct 29, 2021
17606618 INTRACORPOREAL GUIDE COMPONENT Corlife Ohg BACHMAN, LINDSEY MICHELE 3771 §103§112 Final Rejection 51d overdue Pending Oct 26, 2021
17603997 METHODS AND COMPOSITIONS FOR TREATMENT OF NLRP3 INFLAMMASOME MEDIATED IL-1BETA DEPENDENT DISORDERS UNIVERSITE COTE D'AZUR SIMMONS, CHRIS E 1622 §103§112 Final Rejection 56d Pending Oct 15, 2021
17600957 METHODS OF PREDICTING AND PREVENTING CANCER IN PATIENTS HAVING PREMALIGNANT LESIONS Trustees Of Boston University ESSEX, LAURA ANN 1675 §112 Non-Final OA — Pending Oct 01, 2021
17599235 MUTATED ADENO-ASSOCIATED VIRUS CAPSID PROTEINS, AAV PARTICLE COMPRISING THE SAME AND LIVER DIRECTED AAV VECTOR GENE THERAPY Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. SPENCER, ANDREA LYNNE MORRIS 1631 §102§103 Final Rejection 34d Pending Sep 28, 2021
17299481 METHOD FOR LOCATING AND CHARACTERIZING BIFURCATIONS OF A CEREBRAL VASCULAR TREE, ASSOCIATED METHODS AND DEVICES Centre National De La Recherche Scientifique BURKE, TIONNA M 2178 §103 Final Rejection — Pending Jun 03, 2021
17282491 METHODS AND SYSTEMS FOR CONTROLLING THE AGONISTIC PROPERTIES OF ANTIBODY VARIABLE DOMAINS BY LIGHT UNIVERSITE D'AIX-MARSEILLE ROONEY, NORA MAUREEN 1641 §103§112Other Non-Final OA — Pending Apr 02, 2021
17282580 METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MUCOSAL INFLAMMATORY DISEASES Enios Applications Private Limited Company SULLIVAN, DENNIS JOHN 1642 §112 Non-Final OA — Pending Apr 02, 2021
17274966 METHODS FOR INCREASING FETAL HEMOGLOBIN CONTENT IN EUKARYOTIC CELLS AND USES THEREOF FOR THE TREATMENT OF HEMOGLOBINOPATHIES Fondation Imagine SULLIVAN, STEPHANIE LAUREN 1635 §103§112 Non-Final OA 12d Pending Mar 10, 2021
17040342 INDWELLING VENOUS CANNULA Ebnet Medical GmbH OSINSKI, BRADLEY JAMES 3783 §103 Final Rejection 20d Pending Sep 22, 2020
17040246 METHOD FOR REPROGRAMMING SOMATIC CELLS UNIVERSITE CLAUDE BERNARD - LYON 1 BERTOGLIO, VALARIE E 1632 §112 Final Rejection 12d Pending Sep 22, 2020
17040109 METHODS FOR MODULATING INNATE LYMPHOID CELL ACTIVITY, ANTIBODY DRUG CONJUGATES AND USES IN THERAPY UNIVERSITE D'AIX-MARSEILLE MIDDLETON, DANAYA L 1674 §103§112 Non-Final OA 10d overdue Pending Sep 22, 2020
16970810 METHOD AND APPARATUS FOR SIMULTANEOUS 4D ULTRAFAST BLOOD FLOW AND TISSUE DOPPLER IMAGING OF THE HEART AND RETRIEVING QUANTIFICATION PARAMETERS UNIVERSITE DE PARIS BEGEMAN, ANDREW W 3798 §103 Non-Final OA — Pending Aug 18, 2020

Managing Wc&F Ip's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month